IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 6
- 206010006187 Breast cancer Diseases 0.000 abstract 5
- 208000026310 Breast neoplasm Diseases 0.000 abstract 5
- 230000014509 gene expression Effects 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000002493 microarray Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003753 real-time PCR Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (fr) | 2012-05-22 | 2013-05-22 | Gènes nano-46 et procédés de prédiction de l'évolution du cancer du sein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02418A true IN2014MN02418A (fr) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2418MUN2014 IN2014MN02418A (fr) | 2012-05-22 | 2013-05-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (fr) |
| EP (1) | EP2852689B1 (fr) |
| JP (1) | JP6325530B2 (fr) |
| CN (2) | CN104704128A (fr) |
| AU (1) | AU2013266419B2 (fr) |
| BR (1) | BR112014029300A2 (fr) |
| CA (1) | CA2874492C (fr) |
| ES (1) | ES2763931T3 (fr) |
| IL (1) | IL235795B (fr) |
| IN (1) | IN2014MN02418A (fr) |
| MX (1) | MX369628B (fr) |
| WO (1) | WO2013177245A2 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2457534T3 (es) | 2008-05-30 | 2014-04-28 | The University Of North Carolina At Chapel Hill | Perfiles de expresión génica para predecir desenlaces en cáncer de mama |
| EP2685988A4 (fr) | 2011-03-15 | 2014-08-20 | Univ North Carolina | Méthodes de traitement du cancer du sein par une thérapie par anthracycline |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| JP6144695B2 (ja) | 2011-11-30 | 2017-06-07 | ユニバーシティー オブ ノースカロライナ アット チャペル ヒル | タキサン療法を用いて乳癌を処置する方法 |
| EP4592400A3 (fr) | 2012-10-17 | 2025-10-29 | 10x Genomics Sweden AB | Procédés et produits pour optimiser la detection localisée ou spatiale de l'expression génique dans un échantillon de tissu |
| JP2016519935A (ja) * | 2013-05-13 | 2016-07-11 | ナノストリング テクノロジーズ，インコーポレイティド | 結節陽性の初期乳癌における再発リスクを予測する方法 |
| CA2916662C (fr) | 2013-06-25 | 2022-03-08 | Prognosys Biosciences, Inc. | Procedes et systemes pour determiner des motifs spatiales de cibles biologiques dans un echantillon |
| CA2923166A1 (fr) * | 2013-09-09 | 2015-03-12 | British Columbia Cancer Agency Branch | Procedes et kits de prevision de resultat et procedes et kits pour le traitement du cancer du sein par radiotherapie |
| WO2016081740A1 (fr) | 2014-11-21 | 2016-05-26 | Nanostring Technologies, Inc. | Séquençage sans enzyme ni amplification |
| KR102602507B1 (ko) * | 2014-11-24 | 2023-11-14 | 나노스트링 테크놀로지스, 인크. | 유전자 정제 및 이미징을 위한 방법 및 장치 |
| CA2969163A1 (fr) * | 2014-12-09 | 2016-06-16 | King's College London | Traitement du cancer du sein avec une therapie au taxane |
| EP3901282B1 (fr) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Analyse de plusieurs acides nucléiques spatialement différenciés de spécimens biologiques |
| WO2017014694A1 (fr) * | 2015-07-23 | 2017-01-26 | National University Of Singapore | Wbp2 en tant que facteur de co-pronostic avec her2 pour la stratification de patients pour le traitement |
| CN116200462B (zh) | 2016-05-16 | 2025-10-03 | 布鲁克空间生物学公司 | 用于检测样品中目标核酸的方法 |
| US11352667B2 (en) | 2016-06-21 | 2022-06-07 | 10X Genomics, Inc. | Nucleic acid sequencing |
| WO2018074865A2 (fr) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | Composition et procédé pour la prédiction de pronostic du cancer du sein |
| EP4556575A3 (fr) | 2016-11-21 | 2025-10-08 | Bruker Spatial Biology, Inc. | Procédé de séquençage d'acides nucléiques |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| WO2018144782A1 (fr) * | 2017-02-01 | 2018-08-09 | The Translational Genomics Research Institute | Procédés de détection de variants somatiques et de lignée germinale dans des tumeurs impures |
| CN120210336A (zh) | 2017-10-06 | 2025-06-27 | 10X基因组学有限公司 | Rna模板化连接 |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| EP3794146B1 (fr) | 2018-05-14 | 2025-12-10 | Bruker Spatial Biology, Inc. | Méthode d'identifcation d'une séquence nucléotide predeterminée |
| US20210371936A1 (en) * | 2018-11-05 | 2021-12-02 | Biontech Diagnostics Gmbh | Predictive methods in breast cancer |
| CN119220641A (zh) | 2019-05-31 | 2024-12-31 | 10X基因组学有限公司 | 检测目标核酸分子的方法 |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| EP4484571A3 (fr) | 2020-02-21 | 2025-03-19 | 10X Genomics, Inc. | Procédés et compositions pour un dosage spatial in situ intégré |
| US12209273B2 (en) | 2020-06-12 | 2025-01-28 | 10X Genomics, Inc. | Nucleic acid assays using click chemistry bioconjugation |
| EP3945136A1 (fr) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | Procédé in vitro pour le pronostic de patients souffrant d'un cancer du sein her2-positif |
| US12297499B2 (en) | 2020-08-17 | 2025-05-13 | 10X Genomics, Inc. | Multicomponent nucleic acid probes for sample analysis |
| US12509717B2 (en) | 2020-12-11 | 2025-12-30 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| AU2022419002A1 (en) * | 2021-12-20 | 2024-08-01 | Fundació De Recerca Clínic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer | Development and validation of an in vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| CN117965734B (zh) * | 2024-02-02 | 2024-09-24 | 奥明星程(杭州)生物科技有限公司 | 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5770358A (en) | 1991-09-18 | 1998-06-23 | Affymax Technologies N.V. | Tagged synthetic oligomer libraries |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| CA2124087C (fr) | 1991-11-22 | 2002-10-01 | James L. Winkler | Techniques combinees pour la synthese de polymeres |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (fr) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| HUE050365T2 (hu) | 2003-06-24 | 2022-09-28 | Genomic Health Inc | Rákkiújulás valószínûségének elõrejelzése |
| US20050071087A1 (en) * | 2003-09-29 | 2005-03-31 | Anderson Glenda G. | Systems and methods for detecting biological features |
| US20080032293A1 (en) | 2004-07-15 | 2008-02-07 | The University Of North Carolina At Chapel Hill | Housekeeping Genes And Methods For Identifying Same |
| CN101057144A (zh) * | 2004-09-22 | 2007-10-17 | 三路影像公司 | 用于评价乳腺癌预后的方法和组合物 |
| EP1954708A4 (fr) | 2005-11-23 | 2009-05-13 | Univ Utah Res Found | Methodes et compositions dans lesquelles sont utilises des genes intrinseques |
| WO2007076128A2 (fr) | 2005-12-23 | 2007-07-05 | Nanostring Technologies, Inc. | Nanorapporteurs et procedes de production et d'utilisation de ceux-ci |
| JP5700911B2 (ja) | 2005-12-23 | 2015-04-15 | ナノストリング テクノロジーズ，インコーポレーテッド | 配向され、固定化された巨大分子を含む組成物とその製造法 |
| CA2687292C (fr) | 2007-04-10 | 2017-07-04 | Nanostring Technologies, Inc. | Procedes et systemes informatiques pour identifier des sequences specifiques d'une cible afin de les utiliser dans des nanoreporteurs |
| WO2008150512A2 (fr) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Procédés pour identifier une plus grande probabilité de récidive du cancer du sein |
| JP2010538609A (ja) * | 2007-09-06 | 2010-12-16 | バイオセラノスティクス，インコーポレイティド | 腫瘍グレード分類と癌の予後診断 |
| ES2457534T3 (es) | 2008-05-30 | 2014-04-28 | The University Of North Carolina At Chapel Hill | Perfiles de expresión génica para predecir desenlaces en cáncer de mama |
| US8519115B2 (en) | 2008-08-14 | 2013-08-27 | Nanostring Technologies, Inc. | Stable nanoreporters |
| EP2845911B1 (fr) * | 2010-03-31 | 2016-05-18 | Sividon Diagnostics GmbH | Procédé de prédiction de la récurrence du cancer du sein sous traitement endocrinien |
-
2013
- 2013-05-22 CA CA2874492A patent/CA2874492C/fr active Active
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/fr active Active
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/fr not_active Ceased
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013266419A1 (en) | 2014-12-11 |
| CN111500718A (zh) | 2020-08-07 |
| BR112014029300A2 (pt) | 2017-07-25 |
| CA2874492C (fr) | 2021-10-19 |
| EP2852689A4 (fr) | 2016-05-11 |
| US20200332368A1 (en) | 2020-10-22 |
| ES2763931T3 (es) | 2020-06-01 |
| MX369628B (es) | 2019-11-14 |
| EP2852689A2 (fr) | 2015-04-01 |
| AU2013266419B2 (en) | 2018-09-27 |
| JP6325530B2 (ja) | 2018-05-16 |
| WO2013177245A3 (fr) | 2015-01-29 |
| CN104704128A (zh) | 2015-06-10 |
| CA2874492A1 (fr) | 2013-11-28 |
| IL235795A0 (en) | 2015-01-29 |
| IL235795B (en) | 2020-02-27 |
| US20230272476A1 (en) | 2023-08-31 |
| US20130337444A1 (en) | 2013-12-19 |
| MX2014014275A (es) | 2015-07-06 |
| JP2015518724A (ja) | 2015-07-06 |
| EP2852689B1 (fr) | 2019-12-11 |
| WO2013177245A2 (fr) | 2013-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02418A (fr) | ||
| CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
| MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
| EP2663656A1 (fr) | Variants génétiques comme marqueurs à utiliser dans l'évaluation du risque, le diagnostic, le pronostic et le traitement du cancer de la vessie | |
| EA201370063A1 (ru) | Фосфолипидом рака | |
| NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
| NZ709167A (en) | Compositions and methods for diagnosing thyroid tumors | |
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| WO2010051314A3 (fr) | Classification génomique de carcinomes pulmonaires non à petites cellules en fonction de profils d'altérations du nombre de copies de gènes | |
| NZ701652A (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| WO2009009752A3 (fr) | Modèles génétiques pour le classement des risques de cancer | |
| HK1222888A1 (zh) | 预测在淋巴结阳性早期乳癌复发风险的方法 | |
| WO2019089858A3 (fr) | Procédés d'évaluation ou de surveillance d'une réponse à une thérapie cellulaire | |
| RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
| MX360225B (es) | Ensayos de receptores de esteroides para detectar celulas tumorales. | |
| MX2017004816A (es) | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. | |
| Eapen | Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant? | |
| GB201001950D0 (en) | Infection prognostic assay | |
| RU2011134465A (ru) | Метод оценки предрасположенности человека к онкологическим заболеваниям на основе значимых полиморфизмов единичных нуклеотидов | |
| WO2011133500A3 (fr) | Détection et analyse des changements épigénétiques et génétiques dans le tissu tumoral | |
| HK1199097A1 (zh) | 用於癌症治疗的预测物 | |
| UA108260U (uk) | Спосіб прогнозування розвитку остеопорозу | |
| UA95616U (uk) | Спосіб прогнозування зрощення перелому | |
| UA59264U (ru) | Способ прогнозирования индивидуальной склонности к развитию преэклампсии у беременных | |
| Brennan | Quantifying Biomarker Risks and Benefits |